Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Detection of collagens by multispectral optoacoustic tomography as an imaging biomarker for Duchenne muscular dystrophy.

Regensburger AP, Fonteyne LM, Jüngert J, Wagner AL, Gerhalter T, Nagel AM, Heiss R, Flenkenthaler F, Qurashi M, Neurath MF, Klymiuk N, Kemter E, Fröhlich T, Uder M, Woelfle J, Rascher W, Trollmann R, Wolf E, Waldner MJ, Knieling F.

Nat Med. 2019 Dec;25(12):1905-1915. doi: 10.1038/s41591-019-0669-y. Epub 2019 Dec 2.

PMID:
31792454
2.

Viltolarsen for the treatment of Duchenne muscular dystrophy.

Roshmi RR, Yokota T.

Drugs Today (Barc). 2019 Oct;55(10):627-639. doi: 10.1358/dot.2019.55.10.3045038. Review.

PMID:
31720560
3.

Commentary on "The Effect of Inspiratory Muscle Training on Duchenne Muscular Dystrophy: A Meta-analysis".

Moore JG, Cahalin LP.

Pediatr Phys Ther. 2019 Oct;31(4):330. doi: 10.1097/PEP.0000000000000641. No abstract available.

PMID:
31568375
4.

The Effect of Inspiratory Muscle Training on Duchenne Muscular Dystrophy: A Meta-analysis.

Williamson E, Pederson N, Rawson H, Daniel T.

Pediatr Phys Ther. 2019 Oct;31(4):323-330. doi: 10.1097/PEP.0000000000000648.

PMID:
31568374
5.

Cardiac Pathophysiology and the Future of Cardiac Therapies in Duchenne Muscular Dystrophy.

Meyers TA, Townsend D.

Int J Mol Sci. 2019 Aug 22;20(17). pii: E4098. doi: 10.3390/ijms20174098. Review.

6.

Genetic analysis of 1051 Chinese families with Duchenne/Becker Muscular Dystrophy.

Kong X, Zhong X, Liu L, Cui S, Yang Y, Kong L.

BMC Med Genet. 2019 Aug 14;20(1):139. doi: 10.1186/s12881-019-0873-0.

7.

Is Molecular Diagnosis Necessary for Children with Duchenne Muscular Dystrophy?

Puri RD.

Indian Pediatr. 2019 Jul 15;56(7):549-550. No abstract available.

PMID:
31333206
8.

Conservative gadolinium administration to patients with Duchenne muscular dystrophy: decreasing exposure, cost, and time, without change in medical management.

Lang SM, Alsaied T, Moore RA, Rattan M, Ryan TD, Taylor MD.

Int J Cardiovasc Imaging. 2019 Dec;35(12):2213-2219. doi: 10.1007/s10554-019-01670-1. Epub 2019 Jul 18.

PMID:
31321653
9.

Risk Factors for Cerebral Infarction in Duchenne Muscular Dystrophy: Review With our 2 Cases.

Nozaki F, Kusunoki T, Kumada T, Shibata M, Fujii T.

J Stroke Cerebrovasc Dis. 2019 Sep;28(9):2453-2458. doi: 10.1016/j.jstrokecerebrovasdis.2019.06.023. Epub 2019 Jul 13. Review.

PMID:
31311695
10.

Adapting traditional content validation methods to fit purpose: an example with a novel video assessment and training materials in Duchenne muscular dystrophy (DMD).

White MK, Leffler M, Rychlec K, Jones C, McSherry C, Walker L, Kosinski M.

Qual Life Res. 2019 Nov;28(11):2979-2988. doi: 10.1007/s11136-019-02245-2. Epub 2019 Jul 13.

11.

Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy.

Alfano LN, Charleston JS, Connolly AM, Cripe L, Donoghue C, Dracker R, Dworzak J, Eliopoulos H, Frank DE, Lewis S, Lucas K, Lynch J, Milici AJ, Flynt A, Naughton E, Rodino-Klapac LR, Sahenk Z, Schnell FJ, Young GD, Mendell JR, Lowes LP.

Medicine (Baltimore). 2019 Jun;98(26):e15858. doi: 10.1097/MD.0000000000015858.

12.

Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases.

Tsoumpra MK, Fukumoto S, Matsumoto T, Takeda S, Wood MJA, Aoki Y.

EBioMedicine. 2019 Jul;45:630-645. doi: 10.1016/j.ebiom.2019.06.036. Epub 2019 Jun 27. Review.

13.

Association between pulmonary function and left ventricular volume and function in duchenne muscular dystrophy.

Khokhar A, Nair A, Midya V, Kumar A, Sinharoy A, Ahmad TA, Abu-Hasan M, Mondal P.

Muscle Nerve. 2019 Sep;60(3):286-291. doi: 10.1002/mus.26623. Epub 2019 Jul 10.

PMID:
31250930
14.

First psychotic episode in an adult with Becker muscular dystrophy.

Santos CF.

Braz J Psychiatry. 2019 May-Jun;41(3):272-273. doi: 10.1590/1516-4446-2018-0350. Epub 2019 Jun 10. No abstract available.

15.

Scoliosis in Duchenne muscular dystrophy children is fully reducible in the initial stage, and becomes structural over time.

Choi YA, Shin HI, Shin HI.

BMC Musculoskelet Disord. 2019 Jun 7;20(1):277. doi: 10.1186/s12891-019-2661-6.

16.

MLPA Analyses Reveal a Spectrum of Dystrophin Gene Deletions/Duplications in Pakistani Patients Suspected of Having Duchenne/Becker Muscular Dystrophy: A Retrospective Study.

Ansar Z, Nasir A, Moatter T, Khan S, Kirmani S, Ibrahim S, Imam K, Ather A, Samreen A, Hasan Z.

Genet Test Mol Biomarkers. 2019 Jul;23(7):468-472. doi: 10.1089/gtmb.2018.0262. Epub 2019 May 31. Review.

PMID:
31157985
17.

Therapeutic developments for Duchenne muscular dystrophy.

Verhaart IEC, Aartsma-Rus A.

Nat Rev Neurol. 2019 Jul;15(7):373-386. doi: 10.1038/s41582-019-0203-3. Review.

PMID:
31147635
18.

Mutation pattern in 606 Duchenne muscular dystrophy children with a comparison between familial and non-familial forms: a study in an Indian large single-center cohort.

Polavarapu K, Preethish-Kumar V, Sekar D, Vengalil S, Nashi S, Mahajan NP, Thomas PT, Sadasivan A, Warrier M, Gupta A, Arunachal G, Debnath M, Keerthipriya MS, Pradeep-Chandra-Reddy C, Puttegowda A, John AP, Tavvala A, Gunasekaran S, Sathyaprabha TN, Chandra SR, Kramer B, Delhaas T, Nalini A.

J Neurol. 2019 Sep;266(9):2177-2185. doi: 10.1007/s00415-019-09380-3. Epub 2019 May 28.

PMID:
31139960
19.

Rapidly Progressive Heart Failure in a Female Carrier of Becker Muscular Dystrophy with No Skeletal Muscle Symptoms.

Komoriyama H, Fukushima A, Takahashi Y, Kinugawa S, Sera F, Ohtani T, Nakamura A, Sakata Y, Anzai T.

Intern Med. 2019 Sep 1;58(17):2545-2549. doi: 10.2169/internalmedicine.2714-19. Epub 2019 May 22.

20.

Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial.

Dittrich S, Graf E, Trollmann R, Neudorf U, Schara U, Heilmann A, von der Hagen M, Stiller B, Kirschner J, Pozza RD, Müller-Felber W, Weiss K, von Au K, Khalil M, Motz R, Korenke C, Lange M, Wilichowski E, Pattathu J, Ebinger F, Wiechmann N, Schröder R; German Competence Network for Congenital Heart Defects and the Treat-NMD Neuromuscular Network Investigators list of additional local Investigators and co-workers of the German Competence Network for Congenital Heart Defects and the Treat-NMD Neuromuscular Network.

Orphanet J Rare Dis. 2019 May 10;14(1):105. doi: 10.1186/s13023-019-1066-9.

Supplemental Content

Loading ...
Support Center